Transcode Therapeutics RNAZ
NASDAQ RNAZ
$1.40 +0.05 (+3.70%)
At close: Nov 11, 2026 · 4:00 PM EST

Transcode Therapeutics (RNAZ) Preferred Dividend Payments (2026)

Updated

Transcode Therapeutics (RNAZ) recorded Preferred Dividend Payments of $115,015 in Q2 2026, down 93.3% from the prior quarter.

Analysis

Transcode Therapeutics (RNAZ) Preferred Dividend Payments (2026) Analysis & Trends

For FY2025, Transcode Therapeutics reported Preferred Dividend Payments of $1.61 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Transcode Therapeutics 1.37 Mn -40.52 Mn - 115,015.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 115,015.00
Mar 31, 2026 1.73 Mn
API Access

Transcode Therapeutics Preferred Dividend Payments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=RNAZ&period=max&api_key=YOUR_API_KEY